Glow Protocol

The Glow Protocol combines three peptides in a single vial: GHK-Cu (the copper tripeptide), BPC-157, and TB-500 (a synthetic 7-amino-acid fragment of thymosin beta-4). It is used as a once-daily subcutaneous injection.

The thinking behind the combination is that the three peptides act on different but overlapping pathways: collagen and dermal matrix support from GHK-Cu, tissue and gut effects from BPC-157, and angiogenic and migration-related effects from TB-500. Patients who want both skin-quality work and broader tissue support sometimes prefer a single shot to running three separate protocols.

There is no published peer-reviewed literature on this exact three-peptide combination. The evidence for each individual component is what we have to work from. We’re honest about that with every patient who asks. The combination format is a clinical convenience, not a clinically validated formulation.

Daily dosing is the point of this protocol. One injection covers three peptides at once, which is why patients pick it over running three separate vials. The 8 to 12 week cycle gives the slower-moving effects (skin remodeling, hair density) time to show up.

Patients who are already using a topical GHK-Cu serum often continue that during the cycle, especially around microneedling and laser sessions. The topical and the injectable work different parts of the same problem.

Two things to flag honestly. There is no published study on this exact three-peptide combination. And TB-500 is on WADA’s prohibited substance list (S2). We don’t recommend this protocol for anyone subject to drug testing.

The Glow Protocol runs alongside hands-on aesthetic work. This protocol is often used to supplement other services like SkinPen microneedling, RF microneedling, ProFractional, Contour TRL, and our broader laser series.